Gastroparesis Market Insights 2025-2034: Growth Dynamics, Trends, and Strategic Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the gastroparesis market grown in recent years?
The market for gastroparesis has seen a gradual increase in its size in the last few years. The market is set to expand from its 2024 size of $6.84 billion to $7.17 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 4.9%. The previous period of growth can be ascribed to factors such as the ageing population, a rise in diabetes cases, better comprehension of gastro-related conditions, development in treatment methodology, and heightened awareness of gastroparesis.
How is the gastroparesis market size expected to evolve during the forecast period?
The market for gastroparesis is projected to witness significant expansion in the forthcoming years. The anticipated market value is $8.82 billion by 2029, progressing at a compound annual growth rate (CAGR) of 5.3%. The expected growth during the forecast period can be accredited to the innovations in therapeutic treatments, the proliferation of individualized medicine tactics, the incorporation of digital health solutions, the escalation in health care facilities, and a rising emphasis on early diagnosis. Key trends for the predicted period include progression in gastric electrical stimulation therapy, burgeoning research in stem cell treatment, the shift towards minimally invasive surgical procedures, growing dependency on wearable health monitoring gadgets, and emphasis on patient-centered care paradigms.
Get your gastroparesis market report here!
https://www.thebusinessresearchcompany.com/report/gastroparesis-global-market-report
Which key drivers are propelling the gastroparesis market’s growth?
The rise in funds dedicated to health services is expected to enhance the expansion of the gastroparesis market. These health care expenditures cover costs attributed to hospitals, health professionals, nursing, dental care, medications, and public health measures, among other things. The amplified expenditure in healthcare can be linked to aspects such as an increasing elderly population, medical technology advancements, higher rates of chronic diseases, and escalating consumer demands for better healthcare provisions. This upsurge in health care spending positively influences the gastroparesis market by providing increased monetary support for exploration and progression, widening the range of treatment options, and granting patients enhanced access to specialized medical services. For example, a study by the Office for National Statistics, a UK government department, stated that, from 2022 to 2023, healthcare outlays in the UK rose by 5.6% as opposed to the 0.9% growth in 2022. It was documented that the UK expended approximately $317.63 billion (£292 billion) on healthcare in 2023. Consequently, the progression of healthcare spending is stimulating the growth of the gastroparesis market.
What are the market segments in the gastroparesis industry?
The gastroparesis market covered in this report is segmented –
1) By Treatment Modality: Medications, Dietary Modifications, Medical Devices, Other Therapies
2) By Gastroparesis Type: Idiopathic, Diabetic, Post- Surgical, Other Types
3) By Patient Demographics: Pediatric Gastroparesis, Adult Gastroparesis
4) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Other Distribution Channels
5) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Home Care Settings
Subsegments:
1) By Medications: Prokinetic Agents, Antiemetic Medications, Pain Management Medications
2) By Dietary Modifications: Low-Fiber Diets, Small, Frequent Meals, Pureed Or Liquid Diets
3) By Medical Devices: Gastric Electrical Stimulation Devices, Enteral Feeding Tubes
4) By Other Therapies: Acupuncture, Behavioral Therapies, Nutritional Supplements
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12189&type=smp
Which leading companies are shaping the growth of the gastroparesis market?
Major companies operating in the gastroparesis market include Pfizer Inc., GlaxoSmithKline plc., Abbott Laboratories Inc., AstraZeneca Plc., Medtronic Plc., Takeda Pharmaceutical Company Limited, Johnson And Johnson Services Inc., Teva Pharmaceutical Industries Ltd, AbbVie Inc., Boston Scientific Corporation, Bausch Health Companies Inc., Cadila Pharmaceuticals Ltd., Daewoong Pharmaceutical co. ltd, ReGenXBio Inc., ANI Pharmaceuticals Inc., Dompe Farmaceutici S.p.A, Sucampo Pharmaceuticals Inc., Ironwood Pharmaceuticals Inc., Theravance Biopharma Inc., RedHill Biopharma Ltd., Valeant Pharmaceuticals International Inc., CinRx Pharma LLC., Ritter Pharmaceuticals Inc., Evoke Pharma Inc., Metacrine Inc., Neurogastrx Inc.
What key trends are currently impacting the gastroparesis market’s development?
Leading firms in the gastroparesis market are introducing novel devices aimed at enhancing their market profitability. These therapy tools for gastroparesis, a disease marked by slow stomach emptying, are specially created to control or reduce related symptoms. For example, a US medical device firm, Enterra Medical Inc., unveiled a new therapy named Enterra for gastroparesis treatment in 2022. The Enterra Therapy system leverages an embedded neurostimulator to generate mild electrical pulses, promising potential relief for chronic nausea and vomiting symptoms associated with gastroparesis. This treatment is intended for individuals between the ages of 18 to 70 years who suffer from chronic, uncontrollable nausea and vomiting that is drug-resistant and is associated with gastroparesis of diabetic or idiopathic nature.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12189
Which geographic areas are influencing the growth of the gastroparesis market?
North America was the largest region in the gastroparesis market in 2024. The regions covered in the gastroparesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Specialty Trade Contractors Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/specialty-trade-contractors-global-market-report
Repair and Maintenance Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/repair-and-maintenance-global-market-report
Services Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/services-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: